01—Abstract
Summary
Summary of the 8-K filed January 16, 2024. Cited figures are marked; the original filing is the authoritative source.
Laboratory Corporation of America Holdings (now Labcorp Holdings Inc.) filed this Form 8-K on January 16, 2024 under Item 7.01 (Regulation FD Disclosure) to announce the timing of its fourth quarter and full year 2023 financial results.
The company will release those results before the market opens on Thursday, February 15, 2024, and will host a conference call and webcast beginning at 9 a.m. ET that day. The filing is a scheduling notice rather than a results report, so it contains no financial figures for 2023.
The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The company also states that a webcast replay will be available approximately two hours after the live event, and will remain accessible until February 1, 2025. The accompanying Exhibit 99.1 is a press release dated January 16, 2024 announcing the earnings date.
Its boilerplate describes Labcorp as serving clients in over 100 countries, with more than 60,000 employees, working on over 80%a of new drugs approved by the FDA in 2022, and performing more than 600 million tests for patients. For investors, the key item is the February 15, 2024 earnings date, which is when the 2023 results and guidance will be disclosed.
02—Key points
Key Highlights
- Labcorp will release fourth quarter and full year 2023 financial results before the market opens on Thursday, February 15, 2024.
- A conference call and webcast to discuss the results begins at 9 a.m. ET on February 15, 2024.
- The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
- The webcast is listen-only, and participants may register in advance for dial-in numbers and a unique PIN.
- A webcast replay will be available approximately two hours after the live event and until February 1, 2025.
- The announcement was made under Item 7.01 (Regulation FD Disclosure), with the press release furnished as Exhibit 99.1.
- The company describes itself as serving clients in over 100 countries, with more than 60,000 employees and more than 600 million tests performed for patients.
03—Questions
Frequently Asked Questions
When will Labcorp report its fourth quarter and full year 2023 results?
Labcorp will release its fourth quarter and full year 2023 financial results before the market opens on Thursday, February 15, 2024.
How can investors listen to the earnings discussion?
The company will host a conference call and webcast beginning at 9 a.m. ET on February 15, 2024. The webcast will be live on the Labcorp Investor Relations website, and participants may register there to receive dial-in numbers and a PIN. The webcast and dial-in are listen-only.
Will a recording of the call be available afterward?
Yes. A replay of the webcast will be available approximately two hours after the live event and will remain available until February 1, 2025, through the Labcorp Investor Relations website.
Where will the detailed earnings materials be published?
The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Does this filing include any 2023 financial results?
No. This 8-K is a notice of the earnings release date and call details. The 2023 financial results will be disclosed in the earnings release on February 15, 2024.
04—Continue